1-甲基吲哚-3-甲醛 | 19012-03-4

• 物质功能分类: 有机原料 - 醛类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 1-甲基吲哚-3-甲醛
• 中文别名: 3-甲醛-1-甲基吲哚；1-甲基吲哚-3-甲醇；N-甲基-吲哚-3-甲醛
• 英文名称: N-methyl-3-formylindole
• 英文别名: 1-methylindole-3-carboxaldehyde；1-methyl-1H-indole-3-carbaldehyde；1-methylindole-3-carbaldehyde；1-methyl-1H-indole-3-carboxaldehyde；N-methylindole-3-carbaldehyde；N-methylindole-3-carboxaldehyde
• CAS: 19012-03-4
• 化学式: C₁₀H₉NO
• mdl: MFCD00014570
• 分子量: 159.188
• InChiKey: KXYBYRKRRGSZCX-UHFFFAOYSA-N

物化性质

• 熔点：
  70-72 °C (lit.)
• 沸点：
  186-189 °C(Press: 3-4 Torr)
• 密度：
  1.10±0.1 g/cm3(Predicted)
• 溶解度：
  >23.9 [ug/mL]
• 稳定性/保质期：
  常温常压下稳定，避免与空气和氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  22
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2933990090
• 危险类别：
  IRRITANT
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  常温密闭避光，存于通风干燥的惰性气体环境中。

SDS

Name:	1-Methylindole-3-carboxaldehyde 97% Material Safety Data Sheet
Synonym:
CAS:	19012-03-4

Section 1 - Chemical Product MSDS Name:1-Methylindole-3-carboxaldehyde 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
19012-03-4	1-Methylindole-3-carboxaldehyde	97%	242-750-3

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
Causes respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 19012-03-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Light yellow to orange cryst. powder and chunks
Odor: odorless
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 70 - 72 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: soluble in acetone, diethyl ester
Specific Gravity/Density:
Molecular Formula:
Molecular Weight:

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 19012-03-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-Methylindole-3-carboxaldehyde - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 19012-03-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 19012-03-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 19012-03-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

概述

1-甲基吲哚-3-甲醛是一种无气味的淡黄色至橙色结晶粉末和块状固体。它可用作医药化工合成中的中间体。

安全说明

若吸入1-甲基吲哚-3-甲醛，应将患者移至新鲜空气处；如皮肤接触，脱去污染衣物，并用肥皂水和清水彻底冲洗皮肤；如有不适，请就医；若眼睛接触，分开眼睑，使用流动清水或生理盐水冲洗，并立即就医；如误食，立即漱口，禁止催吐，并应立即就医。

反应信息

• 作为反应物：
  描述：

  1-甲基吲哚-3-甲醛 以 乙醇 、 苯 为溶剂， 生成 4-(1-methyl-1H-indol-3-yl)-1-phenyl-3,3-di-p-tolylazetidin-2-one
  参考文献：
  名称：

  Synthesis of N-(1-methyl-1H-indol-3-yl)methyleneamines and 3,3-diaryl-4-(1-methyl-1H-indol-3-yl)azetidin-2-ones as potential antileishmanial agents

  摘要：

  A series of N-(1-methyl-1H-indol-3-yl)methyleneamines and eight new 3,3-diaryl-4-(1-methyl-1H-indol-3-yl)azetidin-2-ones have been synthesized and screened for their antileishmanial activity against Leishmania major. 3,3-Diaryl-4-(1-methyl-1H-indol-3-yl)azetidin-2-ones have been synthesized by the Staudinger's ketene-imine cycloaddition employing two 2-diazo-1,2-diarylethanones as the precursors of diarylketenes. A marked improvement in anti-parasitic activity is observed by transformation of the methyleneamines to azetidin-2-ones in seven out of eight compounds. Two compounds displayed antileishmanial activity comparable to that of the clinically used antileshmanial drug, amphotericine B. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.06.081
• 作为产物：
  描述：

  (1-甲基-1H-吲哚-3-基)甲胺 在 三乙烯二胺 、 二甲基硫 、 氧气 作用下， 以 二甲基亚砜 为溶剂， 100.0 ℃ 、101.33 kPa 条件下， 反应 24.0h， 以98%的产率得到1-甲基吲哚-3-甲醛
  参考文献：
  名称：

  铜催化的好氧甲基/亚甲基氧化和DABCO-DMSO体系的CH甲酰化反应，用于羰基吲哚和吡咯的合成

  摘要：

  摘要 使用1,4-二氮杂双环[2.2.2]辛烷（DABCO）作为二甲基亚砜（DMSO）的添加剂，开发了铜催化的取代吲哚和吡咯的甲基/亚甲基氧合反应。类似的有氧催化条件也可以用于吲哚的C（3）和吡咯的C（2）的直接C–H甲酰化。 使用1,4-二氮杂双环[2.2.2]辛烷（DABCO）作为二甲基亚砜（DMSO）的添加剂，开发了铜催化的取代吲哚和吡咯的甲基/亚甲基氧合反应。类似的有氧催化条件也可以用于吲哚的C（3）和吡咯的C（2）的直接C–H甲酰化。

  DOI：

  10.1055/s-0031-1290815
• 作为试剂：
  描述：

  L-亮氨酸乙酯 、 Boc-Gly-Ala-OH 在 1-甲基吲哚-3-甲醛 、 acrylamide resin containing isocyano group 、 三氟乙酸 作用下， 生成 Gly-Ala-Leu-OEt
  参考文献：
  名称：

  Arshady, Reza; Ugi, Ivar, Zeitschrift fur Naturforschung, Teil B: Anorganische Chemie, Organische Chemie, 1981, vol. 36, # 9, p. 1202 - 1204

  摘要：

  DOI：

文献信息

• [EN] 2-(1H-INDOLE-3-CARBONYL)-THIAZOLE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS<br/>[FR] DÉRIVÉS DE 2-(1H-INDOLE-3-CARBONYL)-THIAZOLE-4-CARBOXAMIDE ET COMPOSÉS CORRESPONDANTS UTILISÉS EN TANQUE QUE AGONISTES DU RÉCEPTEUR D'HYDROCARBURE ARYLE (AHR) UTILISÉS POUR LE TRAITEMENT DE, P.EX., DE L'ANGIOGENÈSE IMPLIQUÉE OU DE TROUBLES INFLAMMATOIRES
  申请人：IKENA ONCOLOGY INC

  公开号：WO2021127302A1

  公开（公告）日：2021-06-24

  2-(1H-lndole-3-carbonyl)-thiazole-4-carboxamide derivatives and the corresponding imidazole, oxazole and thiophene derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of angiogenesis implicated disorders, such as e.g. retinopathy, psoriasis, rheumatoid arthritis, obesity and cancer, or inflammatory disorders. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 27 to 32 and 59 to 219; examples 1 to 8; compounds 1-1 to 1-97; tables 1-a, 2 and 3).

  2-(1H-吲哚-3-甲酰基)-噻唑-4-羧酰胺衍生物及相应的咪唑、噁唑和噻吩衍生物以及相关化合物作为芳香烃受体（AHR）激动剂，用于治疗涉及血管生成的疾病，例如视网膜病变、银屑病、类风湿性关节炎、肥胖和癌症，或炎症性疾病。本说明书揭示了示例化合物的合成和表征以及其药理数据（例如第27至32页和59至219页；示例1至8；化合物1-1至1-97；表1-a、2和3）。
• 喹唑啉酮并[2,3-a]咔啉衍生物及其制备方法和应用
  申请人：广西师范大学

  公开号：CN113480537B

  公开（公告）日：2022-05-10

  本发明的主要内容是提供合成一种新的喹唑啉酮并[2,3‑a]咔啉化合物及其制备方法和应用，具有通式（Ⅰ）喹唑啉酮并[2,3‑a]咔啉化合物为，或通式（Ⅱ）的喹唑啉酮并[2,3‑a]咔啉化合物为，并提供了该化合物在制备抗炎药物中的应用。
• Unconventional stereoselective one-pot synthesis of Knoevenagel-type indoles via in situ condensation of iminium salts with active methylene reagents
  作者：Angelo Ranise、Francesco Lucchesini、Matteo Caviglia、Silvana Alfei、Andrea Spallarossa、Chiara Caneva

  DOI：10.1016/j.tet.2013.10.086

  日期：2013.12

  Knoevenagel-type indoles is described. The method is based on the in situ reaction of indole iminium salts (four of them are fully characterized) with acyclic symmetrical and unsymmetrical active methylene reagents in the presence of triethylamine. In general, the overall yields are moderate to good. Some of relevant reaction parameters and steric effects affecting stereoselectivity are discussed.

  描述了一种简单的一锅法，用于立体选择性合成Knoevenagel型吲哚。该方法基于在三乙胺存在下吲哚亚胺盐（已充分表征其中的四种）与无环对称和不对称活性亚甲基试剂的原位反应。总的来说，总产量是中等至良好。讨论了影响立体选择性的一些相关反应参数和空间效应。
• A General Carbazole Synthesis via Stitching of Indole–Ynones with Nitromethanes: Application to Total Synthesis of Carbazomycin A, Calothrixin B, and Staurosporinone
  作者：Shweta Singh、Ramesh Samineni、Srihari Pabbaraja、Goverdhan Mehta

  DOI：10.1021/acs.orglett.9b01111

  日期：2019.5.3

  functionalized carbazole frameworks (28 examples). The scope of this new benzannulation has been extended to variants like 2-chloroindole-3-ynones to eventuate in chemo-differentiated 1,2,3,4-tetrasubstituted carbazoles with retention of the nitro group. The efficacy of this strategy has been demonstrated through concise total synthesis of natural products, viz. carbazomycin A, calothrixin B, and staurosporinone

  已经探索了吲哚-3-炔酮和各种硝基甲烷衍生物之间的新的一锅多米诺苯甲环化反应，以广泛进入功能不同的咔唑骨架（28个例子）。这种新的苯并环的作用范围已扩展至诸如2-氯吲哚-3-炔酮之类的变体，从而最终在化学上分化后的1,2,3,4-四取代咔唑中保留了硝基。该策略的功效已通过天然产物的简明全合成证明。卡巴霉素A，杯速霉素B和星形孢菌素（K252c）。
• Palladium Catalyzed Regioselective C4‐Arylation and Olefination of Indoles and Azaindoles
  作者：Neetipalli Thrimurtulu、Arnab Dey、Anurag Singh、Kuntal Pal、Debabrata Maiti、Chandra M. R. Volla

  DOI：10.1002/adsc.201801378

  日期：2019.3.15

  A convergent strategy for the synthesis of biologically relevant C4‐substituted indole scaffolds was demonstrated using Pd(II)‐catalyzed remote C−H functionalization of indoles and azaindoles. The reaction displays high regioselectivity for the C4‐position of indole‐3‐carbaldehydes using glycine as an inexpensive transient directing group. Notable features of this transformation include the selective

  使用Pd（II）催化的吲哚和氮杂吲哚的远程CH功能化，证明了生物相关的C4取代的吲哚支架合成的收敛策略。该反应使用甘氨酸作为廉价的瞬态导向基团，对吲哚-3-甲醛的C4位具有很高的区域选择性。该转变的显着特征包括六元palladacyle的选择性形成和出色的官能团耐受性。

表征谱图